Xu D - Search Results

1

Investigation of the optimal duration of bed rest in the supine position to reduce complications after lumbar puncture combined with intrathecal chemotherapy: a multicenter prospective randomized controlled trial.

Li J, Li X, Tong X, Liu J, Huang B, Chen M, Kuang L, Zhou Z, Xu D. Li J, et al. Among authors: xu d. Support Care Cancer. 2018 Sep;26(9):2995-3002. doi: 10.1007/s00520-018-4142-0. Epub 2018 Mar 15. Support Care Cancer. 2018. PMID: 29546527 Free PMC article. Clinical Trial.

2

[Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia].

Tong XZ, Xu DR, Zou WY, Li J, Luo SK, Peng AH, Zhang GC, Zheng D. Tong XZ, et al. Among authors: xu dr. Ai Zheng. 2007 Aug;26(8):914-8. Ai Zheng. 2007. PMID: 17697559 Free article. Chinese.

3

Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.

Huang XF, Luo SK, Xu J, Li J, Xu DR, Wang LH, Yan M, Wang XR, Wan XB, Zheng FM, Zeng YX, Liu Q. Huang XF, et al. Blood. 2008 Mar 1;111(5):2854-65. doi: 10.1182/blood-2007-07-099325. Epub 2007 Dec 26. Blood. 2008. PMID: 18160664 Free article.

4

[Therapeutic effects of imatinib on chronic myeloid leukemia in different phases and the factors affecting the effects].

Zou WY, Xu DR, Su C, Li J, Luo SK. Zou WY, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(9):1660-2. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18819894 Chinese.

5

[The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma].

Li J, Zhao Y, Luo SK, Huang BH, Zhang GC, Peng AH, Zheng D, Su C, Xu DR, Tong XZ, Gu JL, Ding Y. Li J, et al. Among authors: xu dr. Zhonghua Yi Xue Za Zhi. 2008 Aug 5;88(30):2140-3. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080477 Chinese.

6

[Osteoclast differentiation regulated by receptor activator of nuclear factor kappaB probably through a novel signaling pathway].

Xu DR, Chen HZ, Wang HH, Li J, Luo SK. Xu DR, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):607-11. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19549373 Chinese.

7

[Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease].

Xu DR, Su C, Zou WY, Xu HR, Huang S, Li J, Luo SK. Xu DR, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):376-80. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20416172 Chinese.

8

[Dynamic observations of beta-catenin in chronic myeloid leukemia and its relationship with cytogenetic response].

Zou WY, Xu DR, Su C, Chen M, Li J, Luo SK. Zou WY, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Aug;30(8):1868-70, 1873. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20813688 Chinese.

9

[The clinical features of infection in multiple myeloma undergoing autologous hematopoietic stem cell transplantation].

Li J, Huang BH, Zhou ZH, Zheng D, Xu DR, Zou WY. Li J, et al. Among authors: xu dr. Zhonghua Nei Ke Za Zhi. 2011 Jan;50(1):44-7. Zhonghua Nei Ke Za Zhi. 2011. PMID: 21418888 Chinese.

10

Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells.

Xu DR, Huang S, Long ZJ, Chen JJ, Zou ZZ, Li J, Lin DJ, Liu Q. Xu DR, et al. J Transl Med. 2011 May 21;9:74. doi: 10.1186/1479-5876-9-74. J Transl Med. 2011. PMID: 21600017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,952 results

Search Page

Filters